Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial lung disease (ILD), with an estimated 3-year survival rate of 50% As we previously reported, 6-9% of smokers have interstitial lung abnormalities (ILA) on CT scans. These abnormalities are associated with reduced lung volumes, greater symptoms and exercise impairments, and an increased risk of death. Additional work in the Framingham Heart Study further demonstrated a strong correlation between ILA and polymorphisms in the promoter region of the MUC5B gene. This polymorphism has been strongly linked to the development of interstitial pulmonary fibrosis (IPF). The aggregate of our data suggest that ILA is a clinically relevant CT feature and that a subset of these subjects likely progress to more fulminant interstitial lung disease (ILD) or IPF. Defining new prognostic markers of ILA progression are critical to better determine the patients at a higher risk of ending on a fatal disease course like IPF. The availability over the last year of new effective therapies for IPF makes even more important the need of earlier disease identification where therapeutic attenuation of functional decline will be more impactful than at the latter end stages of established IPF. Our proposal addresses the discovery of ILA presence on CT imaging by means of the delineation of different parenchymal subtypes by patterns in the regional CT attenuation and its distribution throughout the chest. We propose to look at changes of fibrotic tissue within ILA regions to determine the prognostic value of baseline textural CT features for the identification of subjects at greatest risk for the development of IPF. We will test and validate those models in 2000 subjects of the COPDGene cohort with baseline and follow-up information.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21HL140422-01
Application #
9441226
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Postow, Lisa
Project Start
2017-09-15
Project End
2019-08-31
Budget Start
2017-09-15
Budget End
2018-08-31
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Ash, Samuel Y; Harmouche, Rola; Ross, James C et al. (2018) Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort. Radiology 288:600-609
Ramos-Llorden, Gabriel; Vegas-Sanchez-Ferrero, Gonzalo; Bjork, Marcus et al. (2018) NOVIFAST: A Fast Algorithm for Accurate and Precise VFA MRI Mapping. IEEE Trans Med Imaging 37:2414-2427
Onieva, Jorge Onieva; Serrano, Germán González; Young, Thomas P et al. (2018) Multiorgan structures detection using deep convolutional neural networks. Proc SPIE Int Soc Opt Eng 10574:
González, Germán; Washko, George R; Estépar, Raúl San José (2018) Deep learning for biomarker regression: application to osteoporosis and emphysema on chest CT scans. Proc SPIE Int Soc Opt Eng 10574:
Cano-Espinosa, Carlos; González, Germán; Washko, George R et al. (2018) Automated Agatston Score Computation in non-ECG Gated CT Scans Using Deep Learning. Proc SPIE Int Soc Opt Eng 10574:
Vegas-Sánchez-Ferrero, Gonzalo; Ledesma-Carbayo, Maria J; Washko, George R et al. (2018) Autocalibration method for non-stationary CT bias correction. Med Image Anal 44:115-125
Campo, Mónica Iturrioz; Pascau, Javier; José Estépar, Raúl San (2018) EMPHYSEMA QUANTIFICATION ON SIMULATED X-RAYS THROUGH DEEP LEARNING TECHNIQUES. Proc IEEE Int Symp Biomed Imaging 2018:273-276
Ash, Samuel Y; Harmouche, Rola; Putman, Rachel K et al. (2018) Association between acute respiratory disease events and the MUC5B promoter polymorphism in smokers. Thorax 73:1071-1074